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PERSPECTIVE

Assessing the influence of consanguinity on congenital heart
disease
Alan H. Bittles
Centre for Comparative Genomics, Murdoch University, and School of Medical Sciences, Edith Cowan University, Perth, Australia

ABSTRACT
Numerous articles have been published linking consanguineous marriage to an elevated prevalence of congenital
heart disease, with ventricular septal defects and atrial septal defects the most commonly cited disorders. While
initially persuasive, on closer examination many of these studies have fundamental shortcomings in their design
and in the recruitment of study subjects and controls. Improved matching of cases and controls, to include
recognition of the long-established community boundaries within which most marriages are contracted, and
the assessment of consanguinity within specific levels and types of marital union would improve and help to
focus the study outcomes. At the same time, major discrepancies between studies in their reported prevalence
and types of congenital heart disease suggest an urgent need for greater standardization in the classification
and reporting of these disorders.
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INTRODUCTION

unclear. At the most basic level it would be reasonable

Marital unions between close biological kin are common
in many populations, especially in South, Central
and West Asia, and North and sub-Saharan Africa,
and in migrant communities from those regions now
resident in Europe, North America and Oceania. [1]
From a medical genetics perspective, all marriages
between couples related as second cousins or closer are
regarded as consanguineous (derived from the Latin con
sanguineus; i.e. sharing the same blood), and using this
definition, it has been estimated that at least 10.4% of
the current world population of 7.0 billion persons are
consanguineous, with first cousin marriages especially
popular.[1]

demonstrated, it would be indicative of a causative

Despite the many investigations that have been
conducted into the relationship between consanguinity
and congenital heart disease (CHD), the precise
nature and significance of the association remains
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to assume that if a robust relationship could be
mutation or the faulty expression of one or a number
of otherwise rare recessive genes present in the
parents in heterozygous form and adversely affecting
embryonic and fetal development when homozygous.
However, many of the more common CHDs appear
to be genetically heterogeneous, whether diagnosed
as isolated anomalies or accompanied by other heart
defects.[2] If common predisposing genes are involved
in the expression of CHD then, by definition, the
likelihood of an association with consanguinity would
be substantially reduced.[1]
The epidemiological data often are ambiguous, and
although in many instances the results are suggestive
of an association between consanguinity and CHD,
they frequently fail to attain statistical significance.
Several explanations can be advanced for this
shortcoming, relating respectively to the diagnostic
methods and disease criteria that are employed,
the mode of recruitment of study subjects and the
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numbers and types of cases involved, the demographic

DOI:

and communities, and the methods of consanguinity

***

and genetic structures of individual sub-populations
assessment used, with the latter two factors especially
relevant in the context of the Indian subcontinent.
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DIAGNOSTIC METHODS AND CRITERIA
FOR CHD IDENTIFICATION
In most studies, CHD has been diagnosed by
echocardiography and/or cardiac catheterization,
with a birth prevalence of 4–8/1000 typically cited
and approximately 90% of CHD reported as being
multifactorial in origin. [3] However, in a review by
the American Heart Association Congenital Defects
Committee endorsed by the American Academy of
Pediatrics, an overall CHD incidence of 50/1000 births
was described as conservative, on the grounds that a
number of commonly occurring defects are routinely
excluded from prevalence estimates. For example,
bicuspid aortic valve, which affects 10–20/1000 people
in the general population and may be associated with
considerable morbidity and mortality in later life.[4]
Further, in studies on Israeli neonates, the incidence of
ventricular septal defects (VSD) alone was 53/1000.[5]
The scale of the discrepancy in total CHD incidence
between the generally accepted level of 4–8/1000
and 50+/1000 live births therefore raises significant
concerns, and merits detailed attention and explanation.
As a first step it is important to determine exactly
which types of heart defect are under investigation,
the methods of ascertainment employed, the defects
recorded and reported, and of equal importance
which types of CHD were not identified or identifiable
by the study techniques. With just a few exceptions,[5,6]
a consistent positive association has been reported
between consanguinity and VSD and atrial septal defects
(ASD), but both positive and negative associations
between consanguinity and patent ductus arteriosus,
atrioventricular septal defect, pulmonary atresia,
tetralogy of Fallot and other CHDs have been recorded
in different populations.[7-10]
What is presently unclear is whether these interpopulation differences are real and indicative of
population-specific patterns of CHD, which in turn
could be genetic and/or environmental in origin. Or if
they also reflect variable diagnostic capacities, expertise
and experience, the case definitions employed in the
different study centers which have contributed to the
literature, and whether ICD codes for malformations of
the cardiac system were routinely applied, and disorders
were subtyped in terms of embryological timing.

SELECTION AND COMPOSITION OF THE
STUDY SAMPLE
A second area of concern relates to the composition of the
study populations included in CHD investigations. While
neonates only were recruited in a Lebanese study that
reported a significant association between consanguinity
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and CHD,[9] many other widely cited studies variously
recruited symptomatic infants, including some with
chromosomal anomalies such as Down syndrome,
children of differing ages, and even adults in the
third and fourth decades of life.[6-8,10-16] Likewise, while
some studies included control for the potential effects
of sociodemographic and lifestyle variables, such as
maternal age and education, socioeconomic status, and
smoking, and clinical conditions including pre-eclampsia,
maternal diabetes, and pregnancy-induced hypertension,
other studies did not.
Age-independent case selection makes rigorous interstudy comparisons well-nigh impossible, as defects that
would, or at least could, have been diagnosed shortly after
birth may have spontaneously corrected early in life. For
example, in the Israeli study in which no association
was found between consanguinity and the incidence of
VSD, the defects detected were asymptomatic and 89%
closed spontaneously within the first 10 months of life.[5]
This outcome was confirmed in an associated study on
preterm neonates which reported 87.5% spontaneous
closure of VSD by age 6–11 months.[17]
Many of the more seriously affected cases of CHD
diagnosed in developing countries die in childhood,[18]
and unless assessed in early infancy they would not be
included in prevalence statistics. By comparison, adults
who are not diagnosed with CHD until their 20s and 30s
but are included in prevalence statistics presumably do
not have an especially life-threatening condition. Their
inclusion may thus convey an erroneous impression as to
the nature and clinical severity of the underlying cardiac
lesions in the population. With these factors in mind,
the unqualified use of mixed-age study groups in the
investigation of CHD and the calculation of prevalence
rates is questionable. More specifically, in the present
context, is it appropriate to use the results obtained
with such heterogeneous patient groups to assess the
influence of consanguinity on CHD prevalence and
clinical outcomes?

POPULATION STRATIFICATION IN CASE–
CONTROL AND ASSOCIATION STUDIES
To ensure scientific and clinical relevance, case–control
and association studies rely on the close matching of
affected persons with other individuals who do not
exhibit symptoms and have no family history of the
disorder under investigation. As previously noted, for
this reason cases and controls are routinely compared
and matched in terms of age and gender, and with respect
to variables such as residence and socioeconomic status.
While this type of matching might be sufficient when
largely environmental disorders are under investigation,
when a genetic predisposition or cause is suspected
it is of obvious importance that matching in terms of
Annals of Pediatric Cardiology 2011 Vol 4 Issue 2
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inheritance also needs to be ensured.
This requirement is especially important in South Asia
due to the very marked patterns and levels of population
stratification. For example, in India, there are numerous
co-resident ethnicities and religions, some 50,000–60,000
caste and non-caste communities, and up to 30% uncle–
niece and first cousin marriages reported in the southern
states of Andhra Pradesh, Karnataka and Tamil Nadu, and
in southern Maharashtra.[19-22] Similarly, in Pakistan, the
population is subdivided into ethnic communities and
biraderi (literally translated as “brotherhoods”), that is,
traditional social and occupational groupings inherited
through the male lineage, and with first cousin marriage
rates of 40–50+% consistently reported in regional and
national surveys.[23-25] In both countries, the long history of
marriage within strict community boundaries means that
significant genetic differentiation predictably would have
occurred, with some disease mutations unique to specific
communities. Ongoing studies have suggested that on
average each human carries 50–100 genetic variants
that have been implicated in inherited disorders.[26]
Ample opportunities would therefore have existed for
major inter-community genetic differentiation during
the estimated 3000 years since the initial establishment
of the caste system.
It is the routine failure to control for population
genetic subdivisions brought about by community
endogamy that is of greatest significance and concern
in association studies, including the investigation of
CHD. Besides the widely recognized geographical, ethnic
and religious divisions, the genetic effects of caste and
sub-caste endogamy have been clearly demonstrated in
India,[22,27,28] and an equivalent role is played by biraderi
subdivisions in the Muslim populations of India and
Pakistan.[29-31] Yet, in the selection of cases and controls,
little attempt appears to have been made to control for
these differences, despite the clear role of communityspecific founder mutations in many genetic disorders,[1]
for example, β-thalassemia in the populations of the
subcontinent.[32,33]
This problematic situation was demonstrated in a
bibliographic exercise based on information compiled
from PubMed, using the terms association study, case–
control study and clinical trial as keywords and matching
of these terms with caste or biraderi and consanguinity.[34]
Of the 948 association studies published on Indian
populations, only 4.2% mentioned caste, while for 2030
case–control studies the comparable figure was 1.9%,
and for 1381 clinical trials it was 0.5%. The data for
Pakistan were essentially the same, with just 6.6% of
association studies, 1.9% of case–control studies and 0.6%
of clinical trials indicating caste or biraderi affiliations.
The combined data therefore suggest non-recognition
or inadvertent avoidance of the central roles played
Annals of Pediatric Cardiology 2011 Vol 4 Issue 2

by caste and biraderi membership in determining the
genetic structure of South Asian populations.
Failure to account for the probability of inter-community
genetic differences means that the results obtained with
case–control and gene association studies may at least
in part represent flawed recruitment protocols and
thus inappropriate investigative design, which could
explain the notable lack of reproducibility in many
gene association studies. However, another factor to be
considered is that because of the highly endogamous
nature of caste and biraderi lineages, even children
described as “non-consanguineous” because their
parents were unrelated prior to marriage may in fact be
homozygous at a significant proportion of their gene loci.
This phenomenon relates to the deeper ancestral
heritage of humans and has been clearly demonstrated
in studies in Asian, European and North American
populations. [35-38] Even families known not to have
contracted consanguineous marriages for at least 5–10
generations exhibit numerous regions of the genome in
which there are long uninterrupted runs of homozygosity
that are indicative of close kin unions in much earlier
generations.[36,37]

ASSESSING THE INFLUENCE OF
CONSANGUINITY IN CASE–CONTROL
AND ASSOCIATION STUDIES
The situation with regard to non-recognition of the
possible influence of intra-familial marriage in case–
control and association studies is actually more extreme,
with in India consanguinity mentioned in just 1.0%,
0.2% and <0.1% of association studies, case–control
studies, and clinical trials, respectively, possibly due
to the strict avoidance of unions between biological
relatives in many communities. But the fact that only
4.6% of association studies, 4.0% of case–control studies
and no clinical trials conducted in Pakistan discussed
the possible genetic effects of consanguinity in a
country where 40–50+% of all marriages are between
first cousins can be highly misleading, especially for
clinicians and researchers who may be unfamiliar
with the high prevalence of this form of marriage
and its consequences in terms of increased genomic
homozygosity.[34]
Even when consanguinity is included as a variable, as
has been the case in many studies of CHD, the evaluation
very frequently is reduced to a simple “consanguineous”
versus “non-consanguineous” dichotomy. In an uncle–
niece or a double first cousin marriage, the couple is
assumed to have inherited 1/4 of their genes from a
common ancestor, whereas in first cousin unions the
assumption is that the couple has inherited 1/8 of their
genes from a common ancestor, and for a second cousin
113
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couple the comparable proportion is 1/32. This means
that on average the progeny of an uncle–niece or a double
first cousin marriage will be expected to have inherited
identical gene copies at 1/8 of all their loci, defined as a
coefficient of inbreeding F = 0.125. It follows that for first
cousin progeny, F = 0.0625, that is, 1/16 loci predictably
are homozygous, whereas for second cousins, F = 0.0156,
that is, 1/64 of loci are homozygous.[39]
It is unclear and unhelpful why in investigating the
impact of consanguinity on the prevalence and types
of CHD, researchers very frequently have opted to
coalesce three quite distinct levels of consanguinity (F=
0.0156, 0.0625 and 0.125), representing an eightfold
average difference in genomic homozygosity, into a
single ambiguous and ill-defined “consanguineous”
category. Failure to recruit adequate numbers of cases
in each specific category of consanguineous union is not
a sufficient excuse for the adoption of this practice in
order to attain statistical significance.
It is also important to recognize that the preferred
types of consanguineous marriages vary between
communities with, for example, uncle–niece marriages
commonly contracted in Dravidian Hindu communities
in South India, whereas first cousins are by far the
most common form of consanguineous marriage in
Muslim populations.[40] Also, since in many communities
consanguinity is a long-established tradition, the effect
of uninterrupted intra-familial marriages contracted
in successive generations would have resulted in much
higher cumulative coefficients of inbreeding than would
be predicted on the basis of consanguineous marriage
in a parental generation only.[41]
Perhaps because of these complex and variable factors,
it was not unexpected that a study conducted on
consanguineous progeny in Bangalore, the capital of
Karnataka where uncle–niece and first cousin marriages
remain popular, was unable to identify a single gene
of major effect in a clinically heterogeneous cohort
of patients with CHD.[42] As suggested by the authors,
the statistical power of follow-up studies could be
significantly increased by investigating consanguineous
families in which multiple children have been diagnosed
with the same form of CHD. However, a complementary
approach which would enable more genetically
meaningful comparisons to be drawn would be to
match cases and controls according to their community
of origin, rather than simply on the basis of parental
consanguinity.[1,42]

DISCUSSION
Obviously, there must be some practical limitation in
the degree to which cases and controls can be matched,
and control for potential genetic variables is currently
114

much more intractable than for environmental or
sociodemographic factors. At the same time, it should be
incumbent on authors to avoid claims for their findings
that are based on unproven and/or questionable study
designs, particularly when major variables of genetic
significance, such as caste/biraderi affiliation and the
specific levels of consanguinity of individual cases
and controls, have often been effectively ignored or
inadequately controlled.
In India, the selection of cases and controls matched
solely on the basis of personal religion is inadequate
because most members of the Muslim, Christian and
Buddhist communities are the descendants of converts
from Hinduism in the recent or relatively recent past, and
so they would be expected to share significant portions
of their genomes with sectors of the majority Hindu
community.[43] Given the approximately 120 generations
since the establishment of the caste system, the restricted
numbers of founder individuals in each caste, the effects
of subsequent caste sub-divisions, and the action of
genetic drift, the opportunity for genetic differentiation
and the accumulation of caste-specific mutations would
have been equivalently large.
From a global perspective, more appropriate subject
recruitment based on social and demographic realities
should lead to improved investigative outcomes for
CHD and other common disorders. This conclusion
applies not only to South Asia but also to the Middle
East, Africa and many other regions of the world where
clan and tribal affiliations should be integral factors in
the recruitment of cases and controls. At the same time,
to facilitate credible inter-population comparisons, the
standardization of diagnostic methods and particularly
disease classificatory systems needs to be urgently
addressed, together with improved statistical analysis
and reporting of findings. Once these basic changes have
been effected, it should be possible to more accurately
assess the impact of consanguineous marriage on the
health of populations in general, and more specifically
on the prevalence and types of CHD at family and
community levels.
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